First Time Loading...

MorphoSys AG
XETRA:MOR

Watchlist Manager
MorphoSys AG Logo
MorphoSys AG
XETRA:MOR
Watchlist
Price: 66.65 EUR 0.83% Market Closed
Updated: May 3, 2024

MorphoSys AG
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MorphoSys AG
Cash from Financing Activities Peer Comparison

Comparables:
BNTX
CVAC
IMTX
BIO
FYB

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
MorphoSys AG
XETRA:MOR
Cash from Financing Activities
€43m
CAGR 3-Years
-64%
CAGR 5-Years
-25%
CAGR 10-Years
-11%
BioNTech SE
NASDAQ:BNTX
Cash from Financing Activities
-€778.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
CureVac NV
NASDAQ:CVAC
Cash from Financing Activities
€230.9m
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immatics NV
NASDAQ:IMTX
Cash from Financing Activities
€84.5m
CAGR 3-Years
-26%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Biotest AG
XETRA:BIO
Cash from Financing Activities
-€6.8m
CAGR 3-Years
N/A
CAGR 5-Years
43%
CAGR 10-Years
N/A
Formycon AG
XETRA:FYB
Cash from Financing Activities
€40.7m
CAGR 3-Years
33%
CAGR 5-Years
46%
CAGR 10-Years
N/A

See Also

What is MorphoSys AG's Cash from Financing Activities?
Cash from Financing Activities
43m EUR

Based on the financial report for Dec 31, 2023, MorphoSys AG's Cash from Financing Activities amounts to 43m EUR.

What is MorphoSys AG's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-11%

Over the last year, the Cash from Financing Activities growth was -86%. The average annual Cash from Financing Activities growth rates for MorphoSys AG have been -64% over the past three years , -25% over the past five years , and -11% over the past ten years .